Asif Ali sold $1.5M of Protagonist Therapeutics (PTGX)

Executed Mar 12 2025, disclosed Mar 14 2025, 2 days later.

Value, as filed

$1.5M

24,903 sh × $58.73

Executed

Mar 12 2025

the trade date, as filed

Disclosed

Mar 14 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Asif Ali Chief Financial Officer profile →

Asif Ali (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $3.8M of PTGX (46,203 sh across 2 lots, as filed), executed Jan 27.

The name

PTGX

Protagonist Therapeutics, Inc. PTGX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Asif Ali in PTGX

PTGXSALE Protagonist Therapeutics, Inc. $185K
1,750 sh × $105.47
Exec Apr 20
Filed Apr 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $2.6M
24,765 sh × $104.24
Exec Mar 26
Filed Mar 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $3.8M
46,203 sh across 2 lots
Exec Jan 27
Filed Jan 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $708K
8,588 sh × $82.48
Exec Jan 20
Filed Jan 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $534K
12,000 sh × $44.47
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET